GlaxoSmithKline Stock Performance

<div class='circular--portrait' style='background:#FF6600;color: white;font-size:6em;padding-top: 0px;;'>G</div>
GSK -- USA Stock  

Fiscal Quarter End: March 31, 2020  

The company retains Market Volatility (i.e. Beta) of 0.0569, which attests that as returns on market increase, GlaxoSmithKline PLC returns are expected to increase less than the market. However during bear market, the loss on holding GlaxoSmithKline PLC will be expected to be smaller as well. Even though it is essential to pay attention to GlaxoSmithKline PLC current price history, it is always good to be careful when utilizing equity current price movements. Macroaxis philosophy in determining future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. GlaxoSmithKline PLC exposes twenty-eight different technical indicators, which can help you to evaluate its performance. GlaxoSmithKline PLC has an expected return of -0.1268%. Please be advised to check out GlaxoSmithKline PLC Coefficient Of Variation, Semi Variance, Price Action Indicator, as well as the relationship between Treynor Ratio and Daily Balance Of Power to decide if GlaxoSmithKline PLC stock performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Over the last 30 days GlaxoSmithKline PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Regardless of latest conflicting performance, the Stock's technical and fundamental indicators remain consistent and the prevailing confusion on Wall Street may also be a sign of long-lasting gains for the organization traders.
Quick Ratio0.51
Fifty Two Week Low38.43
Target High Price52.00
Fifty Two Week High48.25
Payout Ratio86.01%
Trailing Annual Dividend Yield2.46%
Target Low Price47.00

GlaxoSmithKline PLC Relative Risk vs. Return Landscape

If you would invest  4,548  in GlaxoSmithKline PLC on January 27, 2020 and sell it today you would lose (358.00)  from holding GlaxoSmithKline PLC or give up 7.87% of portfolio value over 30 days. GlaxoSmithKline PLC is generating negative expected returns assuming volatility of 1.0331% on return distribution over 30 days investment horizon. In other words, 9% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
  Risk (%) 
Considering 30-days investment horizon, GlaxoSmithKline PLC is expected to under-perform the market. In addition to that, the company is 1.02 times more volatile than its market benchmark. It trades about -0.12 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.06 per unit of volatility.

GlaxoSmithKline PLC Market Risk Analysis

Sharpe Ratio = -0.1228
Good Returns
Average Returns
Small Returns
Negative ReturnsGSK

GlaxoSmithKline PLC Stock Performance Indicators

Estimated Market Risk
  actual daily
 9 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average GlaxoSmithKline PLC is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding it to a well-diversified portfolio.

GlaxoSmithKline PLC Alerts

Equity Alerts and Improvement Suggestions

GlaxoSmithKline PLC generates negative expected return over the last 30 days
GlaxoSmithKline PLC has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company has 36.63 B in debt with debt to equity (D/E) ratio of 182.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. GlaxoSmithKline PLC has Current Ratio of 0.8 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
GLAXOSMITHKLINE P has about 5.12 B in cash with (5.78 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08.
On February 20, 2020 GlaxoSmithKline PLC paid $ 0.5994 per share dividend to its current shareholders
Latest headline from nasdaqnewsfeed.com: Has A Multiplier potential On Earnings Growth GlaxoSmithKline plc, - NasdaqNewsFeed

GlaxoSmithKline PLC Dividends

GlaxoSmithKline PLC Dividends Analysis

Check GlaxoSmithKline PLC dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Please check Risk vs Return Analysis. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Company logos by clearbit